Fluvoxamine decreases hospitalizations in high-risk adults with COVID-19 (TOGETHER)

Question

Is fluvoxamine effective in preventing hospitalizations in high-risk adults with COVID-19?

Conclusion

In this study, compared with placebo, fluvoxamine decreased hospitalizations in high-risk symptomatic adults with COVID-19.

Reference

Reis G, dos Santos Moreira-Silva EA, Silva DCM, et al, for the TOGETHER investigators. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health 2021;S2214-109X(21)00448-4.

Share This Post!

Recent Posts